IRIS
BOVIS, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.237
NA - Nord America 2.921
AS - Asia 2.439
Continente sconosciuto - Info sul continente non disponibili 671
SA - Sud America 238
AF - Africa 49
OC - Oceania 7
Totale 22.562
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.858
US - Stati Uniti d'America 2.709
SG - Singapore 887
CN - Cina 540
BD - Bangladesh 399
VN - Vietnam 338
FR - Francia 146
BR - Brasile 136
CA - Canada 91
HK - Hong Kong 90
DE - Germania 48
GB - Regno Unito 47
FI - Finlandia 40
AR - Argentina 29
JM - Giamaica 25
MX - Messico 25
EC - Ecuador 24
IQ - Iraq 24
CR - Costa Rica 21
IN - India 20
JP - Giappone 20
CO - Colombia 19
ID - Indonesia 19
NL - Olanda 17
TR - Turchia 14
ES - Italia 13
VE - Venezuela 12
CH - Svizzera 11
PH - Filippine 11
SA - Arabia Saudita 11
ZA - Sudafrica 11
PK - Pakistan 10
KE - Kenya 8
MY - Malesia 8
RU - Federazione Russa 8
CL - Cile 7
DZ - Algeria 7
MA - Marocco 7
PR - Porto Rico 7
AU - Australia 6
HN - Honduras 6
IE - Irlanda 6
NI - Nicaragua 6
NP - Nepal 6
SE - Svezia 6
SV - El Salvador 6
TH - Thailandia 6
GT - Guatemala 5
PT - Portogallo 5
JO - Giordania 4
PE - Perù 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
UA - Ucraina 4
UZ - Uzbekistan 4
BE - Belgio 3
BZ - Belize 3
GR - Grecia 3
PS - Palestinian Territory 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AL - Albania 2
AT - Austria 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
HR - Croazia 2
KH - Cambogia 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
PL - Polonia 2
QA - Qatar 2
RO - Romania 2
SC - Seychelles 2
TN - Tunisia 2
VG - Isole Vergini Britanniche 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GP - Guadalupe 1
GY - Guiana 1
Totale 21.879
Salva come PNG Salva come JPEG
Città #
Genova 7.940
Genoa 4.694
Vado Ligure 1.472
Rapallo 1.376
San Jose 525
Singapore 422
Ashburn 376
Council Bluffs 146
Lauterbourg 127
New York 125
Ho Chi Minh City 109
Beijing 104
Hanoi 90
Hong Kong 84
Santa Clara 82
Los Angeles 69
Milan 46
Bordighera 40
Dallas 39
Rome 37
Frankfurt am Main 32
Helsinki 32
Buffalo 29
Chicago 27
Phoenix 24
Tianjin 21
Atlanta 20
Philadelphia 19
San Francisco 19
Toronto 19
São Paulo 18
Haiphong 17
Tokyo 17
Da Nang 16
Boardman 15
Mexico City 15
Brooklyn 14
Kingston 14
Naples 14
Denver 13
Montreal 13
San José 13
St Louis 13
Charlotte 12
The Bronx 12
Florence 11
Orem 11
Baghdad 10
Brasília 10
Houston 10
London 10
Miami 10
Washington 10
Hải Dương 9
Amsterdam 8
City of London 8
Lappeenranta 8
Memphis 8
Newark 8
Turin 8
Zurich 8
Bari 7
Cardiff 7
Guayaquil 7
Jacksonville 7
Las Vegas 7
Riyadh 7
Rochester 7
Bologna 6
Calgary 6
Figino 6
Jakarta 6
Medford 6
Nairobi 6
Pasadena 6
Salt Lake City 6
San Diego 6
Seattle 6
Alexandria 5
Boston 5
Can Tho 5
Chesapeake 5
Columbus 5
Dhaka 5
Fort Myers 5
Johannesburg 5
Miano 5
Nashville 5
Paris 5
Quito 5
San Juan 5
San Salvador 5
Amman 4
Austin 4
Berlin 4
Bogotá 4
Campinas 4
Detroit 4
Dublin 4
Erie 4
Totale 18.719
Salva come PNG Salva come JPEG
Nome #
mRNA and Viral Vector COVID-19 Vaccines Do Not Affect Male Fertility: A Prospective Study 304
Bloodstream infections in patients living with HIV in the modern cART era 233
A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis 221
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 218
Delineating the application of ultrasound in detecting synovial abnormalities of subtalar joint in juvenile idiopathic arthritis 218
The Slovene version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 209
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome 208
2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism/American college of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative 208
Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology 206
The Croatian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 204
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 196
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?”. 190
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 189
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 188
The Slovak version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 184
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis 181
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 180
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. 179
Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis 177
Development and testing of a hybrid measure of muscle strength in juvenile dermatomyositis for use in routine care 176
The Canadian English and French versions of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 174
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 172
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 166
Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areas 165
Predictors of retention in care in HIV-infected patients in a large hospital cohort in Italy 164
Haploientical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography 163
Outpatient erbium:YAG (2940 nm) laser treatment for snoring: a prospective study on 40 patients 163
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study 162
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis 161
Vascular factors predict polyneuropathy in a non-diabetic elderly population 161
Non-invasive mitochondrial DNA quantification on day 3 predicts blastocyst development: a prospective, blinded, multi-centric study 161
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries 160
The Algerian Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 158
The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 157
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 157
Classification criteria for autoinflammatory recurrent fevers 157
Defining criteria for disease activity States in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. 156
The Bulgarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 154
Impact of acute-phase complications and interventions on 6-month survival after stroke. A prospective observational study 153
The Chilean Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 153
Management of acute ischemic stroke, thrombolysis rate, and predictors of clinical outcome 153
Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force 152
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 152
The Swedish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 151
The Omani Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 151
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 151
The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 149
The Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 149
The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 149
A long-term prognostic value of CT angiography and exercise ECG in patients with suspected CAD 149
The Colombian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 148
The British English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 148
The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 148
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. 147
The Serbian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 147
The Russian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 147
The Afrikaans version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 146
The Hindi version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 145
The Estonian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 144
The Castilian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 144
Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data 144
The Danish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 143
The Latvian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 143
The Lithuanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 142
The Hebrew version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 141
The Swiss French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 141
The Mexican Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 140
The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 140
A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis 140
The Farsi version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 139
The Thai version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 139
The Ukrainian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 138
The Argentinian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 137
The Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 137
The Czech version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 137
Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis. 136
The Georgian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 136
Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS 134
Cervical musculoskeletal impairments in the 4 phases of the migraine cycle in episodic migraine patients 134
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 133
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 132
Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study 132
The Paraguayan Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 132
The Brazilian Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 132
Coronary in-stent restenosis: Assessment with CT coronary angiography 131
The American English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 130
The French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 130
The Norwegian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 129
The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 128
Revised upper limb module for spinal muscular atrophy: 12 month changes 128
The Libyan Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 127
High-resolution Doppler ultrasound in systemic sclerosis: Analysis of digital arteries and nailfold microvasculature using 18-5 MHz and 33-9 MHz probes 125
A data-driven model of disability progression in progressive multiple sclerosis 125
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 125
Temporomandibular Joint Involvement is Associated with Quality of Life, Disability and High Disease Activity in Juvenile Idiopathic Arthritis 125
The Polish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 124
Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF) 123
The Greek version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 123
Three-Dimensional Shape and Surface Features Distinguish Multiple Sclerosis Lesions from Nonspecific White Matter Disease 123
Role of Alveolar β2-Adrenergic Receptors on Lung Fluid Clearance and Exercise Ventilation in Healthy Humans 121
Totale 15.575
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.259
article - articoli 80.476
book - libri 0
conference - conferenze 566
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 217
Totale 162.518
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.354 0 0 83 121 38 148 54 309 148 173 62 218
2022/20231.661 148 157 24 157 222 269 20 132 297 49 154 32
2023/20241.019 41 122 37 117 73 142 92 57 70 63 81 124
2024/20253.342 98 247 127 229 494 428 355 456 124 151 270 363
2025/20266.473 686 192 489 374 747 489 849 281 526 642 514 684
2026/20271.614 640 634 340 0 0 0 0 0 0 0 0 0
Totale 22.562